HLHwai-Jeng Lin

Hwai-Jeng Lin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hwai-Jeng Lin has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Meperidine as the single sedative agent during esophagogastroduodenoscopy, a double‐blind, randomized, controlled study

    by Yu‐Hsi Hsieh, Hwai‐Jeng Lin, Jin‐Jian Hsieh, Kuo‐Chih Tseng, Chih‐Wei Tseng, Tsung‐Hsing Hung, Felix W. Leung

    In Taiwan, unsedated esophagogastroduodenoscopy (EGD) is widely used, but it is uncomfortable for some patients. While meperidine has been adopted in colonoscopy, its use in EGD has not received extensive attention. This was a prospective study to investigate the use of meperidine as a single sedative agent during EGD. One hundred and forty patients were randomized to receive either 25-mg meperidine (n = 70) or placebo (n = 70) by intramuscular injection before EGD. The primary outcome was patient discomfort scores. The secondary outcomes included patient, endoscopist, and EGD-related variables. Patients in the meperidine group reported less discomfort during esophageal intubation (median score of 2.0 and interquartile range [IQR] of 0-4.0 vs median score of 4.8 and IQR of 1.7-7.0, respectively; P < 0.001) and during the procedure (median score of 1.0 [IQR 0-3.1] vs 3.5 [IQR 0-5.6], P = 0.001) than patients in the placebo group. The endoscopist found patients in the meperidine group had better tolerance during esophageal intubation (median score of 1.0 [IQR 0-2.0] vs 2.0 [IQR 1.0-3.0], P = 0.021) and during the procedure (median score of 0 [IQR 0-1.0] vs 1.0 [IQR 0-3.0], P < 0.001). After the procedure more patients in the meperidine group (71.4% vs 35.7%, P < 0.001) experienced self-limited dizziness that prolonged recovery by ∼3.7 min. After receiving meperidine injection, patients had better tolerance and less discomfort during diagnostic EGD (NCT01547520).


    • 26 August 2011
      • Vol. 124  (1341) , 38-44

    Heater probe thermocoagulation for high-risk patients who show rebleeding from peptic ulcers.

    by Yu-Hsi Hsieh, Hwai-Jeng Lin

    To investigate whether heater probe therapy is effective for patients showing rebleeding from peptic ulcers. We retrospectively reviewed the case profiles in our previous studies on endoscopic therapy for high-risk patients with peptic ulcer bleeding in the past two decades. We analysed the outcomes of 191 patients who showed rebleeding after initial endoscopic haemostasis and received endoscopic therapy with heater probe thermocoagulation. . A total of 191 patients showing rebleeding received heater probe thermocoagulation. After re-therapy, 158 patients (82.7%) achieved ultimate haemostasis. Twenty-five of the 33 patients who failed to achieve haemostasis received surgical intervention. Ten patients (5.2%) died within 1 month after re-therapy. Heater probe thermocoagulation can be used as the first choice for management of patients showing rebleeding after initial endoscopic therapy.

  • Long pediatric colonoscope versus intermediate length adult colonoscope for colonoscopy

    by Yu‐Hsi Hsieh, An‐Liang Zhou, Hwai‐Jeng Lin

    Background: Controversy exists on how the length and diameter of colonoscopes affect the quality of colonoscopy. The aim of this study was to compare a long pediatric colonoscope with an intermediate length adult colonoscope with regards to completion rate and cecal intubation time. Whether either scope may be more efficient in any subgroups was also investigated. Methods: Asymptomatic patients admitted to the physical check‐up department of Buddhist Dalin Tzu Chi General Hospital were included. A single endoscopist performed all of the colonoscopic examinations under sedation. Consecutive patients were randomized to undergo colonoscopy with either intermediate length adult colonoscope (CF‐240I) or long pediatric colonoscope (PCF‐240L). The success rate and time required to reach cecum were compared between the two groups. Results: Between April 2005 and February 2006, a total of 918 patients were enrolled. Incomplete colonoscopy occurred in 21 (2.3%) cases (14 in the CF‐240I group and seven in the PCF‐240L group, P > 0.1). The overall cecal mean insertion time was 6.00 ± 3.66 min. There was no significant difference between the CF‐240I and PCF 240L groups with regard to the cecal intubation rate (96.9% vs 98.5%, P = 0.18), the need for abdominal pressure (71.7% vs 73.4%, P = 0.55) and change of position (13.5% vs 11.5%, P = 0.37). However, the cecal intubation time was shorter in the CF‐240I group (5.75 ± 3.18 vs 6.26 ± 3.30 min, P = 0.02). Subgroup analysis by sex, age, and body mass index showed comparable outcomes between the two groups except that the cecal intubation times were significantly shorter in the CF‐240I group when only men (4.78 ± 2.57 vs 5.50 ± 2.93 min, P < 0.01) or those younger than 50 years (5.50 ± 2.90 vs 6.25 ± 3.68 min, P = 0.02) were considered. Conclusion: Cecal intubation time is shorter in patients examined with an intermediate length adult colonoscope, mainly in the subgroups of men and those younger than 50 years of age.


  • Open Access

    Comparing Different Methods of Activating the Variable Stiffness Function of a Pediatric Variable Stiffness Colonoscope

    by Yu-Hsi Hsieh, An-Liang Zhou, Hwai-Jeng Lin

    Previous studies on variable stiffness colonoscopes showed mixed results. Different methods of activating the variable stiffness function were used and might explain part of the controversy. To determine the most efficient way of activating the variable stiffness function, this study compared 3 methods (no activation, regular activation, activation on an as-needed basis) using 1 single type of pediatric variable stiffness colonoscope. Asymptomatic patients admitted for physical check-up at the Buddhist Dalin Tzu Chi General Hospital were included. A single endoscopist performed all of the colonoscopic examinations of patients under sedation using a variable stiffness pediatric colonoscope. Consecutive patients were randomized to undergo colonoscopy using 3 different methods of activating the variable stiffness function: no activation (“no” group), regular activation at descending colon (“regular” group), and activation on an as-needed basis (“as-needed” group). Completion rate, cecal intubation time, and use of adjunct measures were evaluated and compared among the 3 groups. Subgroup analysis by gender was also performed. Between January and July 2006, a total of 250 patients were enrolled. The completion rates of the examinations were 97.6%, 91.7% and 96.4% in the “no”, “regular” and “as-needed” groups, respectively (p = 0.17). The cecal intubation times were 5.6 ± 2.6 minutes, 5.6 ± 2.7 minutes and 6.2 ± 2.3 minutes, respectively (p = 0.22). Multivariate logistic regression analysis showed that activation of the variable stiffness function regularly (odds ratio [OR], 0.53; 95% confidence interval [CI], 0.28, 0.98; p = 0.04) or on an as-needed basis (OR, 0.52; 95% CI, 0.28, 0.97; p = 0.04) were independent factors that were related with less use of abdominal pressure. When only women were considered, the completion rate was lower in the “regular” group (98.0%, 86.8% and 96.5%, p = 0.04). The use of abdominal pressure was more in the “no” group than the other 2 groups (56%, 34% and 33%, p = 0.03). When only men were considered, the cecal intubation time was longer in the “as-needed” group (4.6 ± 1.4, 4.6 ± 1.8 and 5.8 ± 2.5 minutes, p = 0.02). The other outcomes were similar in both genders. The 3 different methods did not result in significantly different completion rates or cecal intubation times. However, activation of the variable stiffness function decreased the need for abdominal pressure. When males and females were considered separately, activation of the variable stiffness function on an as-needed basis in females was the only useful setting.


  • Recurrence of peptic ulcer in uraemic and non‐uraemic patients after Helicobacter pylori eradication: a 2‐year study

    by G.‐Y. Tseng, H.‐J. Lin, C.‐T. Fang, H.‐B. Yang, G.‐C. Tseng, P.‐C. Wang, T.‐L. Hung, Y.‐C. Deng, Y.‐T. Cheng, C.‐H. Huang

    Summary: Background: The role of Helicobacter pylori in the pathogenesis of peptic ulcer disease in patients with uraemia remains unclear.Aim: To evaluate the long‐term effect of H. pylori eradication in these patients.Methods: Uraemic and non‐uraemic patients with peptic ulcer were enrolled in this study. Patients having history of non‐steroidal anti‐inflammatory drugs use or cardiovascular disease that need aspirin use were excluded. After confirmation of H. pylori infection, they received a triple therapy and were followed up for 2 years.Results: Between September 1999 and December 2005, 34 patients (41%) of the end‐stage renal disease [H. pylori (+) group] and 67 (84%) of the non‐uraemic patients with peptic ulcer disease (PU group) received anti‐H. pylori therapy. After triple therapy, 32 (94%) from the end‐stage renal disease group and 64 (96%) from the peptic ulcer group obtained successful eradication. During the 2‐year follow‐up, three patients in the end‐stage renal disease group were excluded because of the presence of cardiovascular disease and aspirin use in two cases and died of heart failure in one case; two patients in peptic ulcer group refused follow‐up. Finally, 29 uraemic and 62 non‐uraemic patients had achieved the follow‐up. Recurrence of peptic ulcer was more in the end‐stage renal disease group than in the peptic ulcer group with intention‐to‐treat analysis (eight of 32, 25% vs. two of 64, 3%, P = 0.001, OR: 10.0, 95% CI: 1.979–50.540) or per‐protocol analysis (eight of 29, 28% vs. two of 62, 3%, P < 0.001, OR: 11.4, 95% CI: 2.245–58.168).Conclusions: Peptic ulcer recurrence after H. pylori eradication is higher in end‐stage renal disease patients with peptic ulcer than in peptic ulcer patients without renal disease. Factors aside from H. pylori play an important role in peptic ulcer recurrence in end‐stage renal disease patients.


  • Factors that predict cecal insertion time during sedated colonoscopy: The role of waist circumference

    by Yu‐Hsi Hsieh, Chin‐Sung Kuo, Kuo‐Chih Tseng, Hwai‐Jeng Lin

    Various factors have been closely linked to the cecal insertion time. These factors include age, sex, body mass index, quality of bowel preparation, doctor's technique, a history of prior hysterectomy, diverticulosis, and constipation. Waist circumference is better than body mass index in assessing abdominal obesity and therefore may be better than body mass index in predicting cecal insertion time. The aim of this study was to evaluate the factors influencing cecal insertion time and the impact of waist circumference. This prospective study was conducted between August 2004 and June 2005 in Buddhist Dalin Tzu Chi General Hospital. Asymptomatic patients admitted to our physical check-up department were enrolled. A single endoscopist performed all colonoscopies under sedation with a single-handed method. Age, sex, body mass index, waist circumference, history of hysterectomy, constipation, bowel cleansing status, and diverticulosis were analyzed. A total of 1022 patients were enrolled. Among them, 996 (97.5%) completed the colonoscopic examinations (472 men and 524 women). The mean +/- SD insertion time was 307 +/- 166 s for men and 403 +/- 195 s for women (P < 0.01). Female sex, poor bowel preparation, smaller waist circumference, lower body mass index and older age were associated with longer insertion time. Waist circumference was better than body mass index in predicting cecal insertion time. Female sex, poor bowel preparation, smaller waist circumference, lower body mass index and older age were associated with a longer insertion time. Waist circumference was a better predictor than body mass index in assessing cecal insertion time.


  • Open Access

    Mucosal polymerase chain reaction for diagnosingHelicobacter pyloriinfection in patients with bleeding peptic ulcers

    by Hwai-Jeng Lin

    Helicobacter pylori (H pylori) has been linked to chronic gastritis, peptic ulcers, gastric cancer and MALT-lymphoma. Conventional invasive tests are less sensitive than non-invasive tests in diagnosing H pylori infection in patients with bleeding peptic ulcers. Polymerase chain reaction is a sensitive and accurate method for diagnosing H pylori infection. The aim of this study was to evaluate the diagnostic role of mucosal polymerase chain reaction for H pylori infection in patients with bleeding peptic ulcers. In patients with bleeding, non-bleeding peptic ulcers and chronic gastritis, we checked rapid urease test, histology, bacterial culture and mucosal polymerase chain reaction for detecting H pylori infection. Positive H pylori infection was defined as positive culture or both a positive histology and a positive rapid urease test. For mucosal polymerase chain reaction of H pylori, we checked vacA (s1a, s1b, s1c, s2, m1, m1T, m2), iceA1, iceA2 and cag A. Between October 2000 and April 2002, 88 patients with bleeding peptic ulcers (males/females: 60/28, gastric ulcers/duodenal ulcers: 55/33), 81 patients with non-bleeding peptic ulcers (males/females: 54/27, gastric ulcers/duodenal ulcers: 45/36) and 37 patients with chronic gastritis (males/females: 24/13) were enrolled in this study. In patients with bleeding peptic ulcers, non-bleeding peptic ulcers and chronic gastritis, 45 patients (51%), 71 patients (88%) and 20 patients (54%) respectively were found to have positive H pylori infection (P<0.001). In patients with bleeding peptic ulcers, non-bleeding peptic ulcers and chronic gastritis, polymerase chain reaction for H pylori infection was positive in 54 patients (61%), 70 patients (86%) and 20 patients (54%) respectively (P<0.001). The sensitivity, positive predictive value and diagnostic accuracy of mucosal polymerase reaction for H pylori infection were significantly lower in patients with bleeding peptic ulcers (84%, 79% and 81%) than in patients with non-bleeding peptic ulcers (99%, 99% and 98%) (P<0.001, P<0.01 and P<0.001 respectively). The sensitivity, negative predictive value and diagnostic accuracy of mucosal polymerase reaction for H pylori were significantly lower in patients with bleeding peptic ulcers (84%, 83% and 81%) than in patients with chronic gastritis (100%, 100% and 100%) (P = 0.02, P = 0.02 and P = 0.001). Mucosal polymerase chain reaction for detecting H pylori infection is not reliable in patients with bleeding peptic ulcers.


  • Helicobacter pylori stool antigen test in patients with bleeding peptic ulcers

    by Hwai‐Jeng Lin, Wen‐Ching Lo, Chin‐Lin Perng, Anna Fen‐Yau Li, Guan‐Ying Tseng, I‐Chen Sun, Yueh‐Hsing Ou

    Background.  Helicobacter pylori has been linked to chronic gastritis, peptic ulcers, gastric cancer and mucosa‐associated lymphoid tissue lymphoma. Invasive tests are less sensitive than noninvasive tests in diagnosing H. pylori infection in patients with bleeding peptic ulcers. The H. pylori stool antigen test has been useful in diagnosing H. pylori in patients with peptic ulcers before and after eradication of H. pylori. The aim of this study was to evaluate the H. pylori stool antigen test in patients with bleeding peptic ulcers.Methods.  Patients with bleeding and nonbleeding peptic ulcers underwent a rapid urease test, histology, bacterial culture and H. pylori stool antigen test. Positive H. pylori infection was defined as a positive culture or both a positive histology and a positive rapid urease test. Helicobacter pylori stool antigen was assessed with a commercial kit (Diagnostec H. pylori antigen EIA Kit, Hong Kong).Results.  Between October 2000 and April 2002, 93 patients with bleeding peptic ulcers (men/women: 78/15, gastric ulcer/duodenal ulcer: 58/35) and 59 patients with nonbleeding peptic ulcers (men/women: 47/12, gastric ulcer/duodenal ulcer: 30/29) were enrolled in this study. Forty‐seven (50.5%) patients with bleeding peptic ulcers and 30 (50.8%) patients with nonbleeding peptic ulcers, were found to be infected with H. pylori (p > .1). Helicobacter pylori stool antigen tests were positive in 54 (58.1%) and 30 (50.8%) patients with bleeding peptic ulcers and nonbleeding peptic ulcers, respectively (p > .1). The sensitivity (82% vs. 93%), specificity (68% vs. 93%), positive predictive value (74% vs. 93%), negative predictive value (77% vs. 93%) and diagnostic accuracy (75% vs. 93%) were all lower in patients with bleeding vs. nonbleeding peptic ulcers. The specificity, positive predictive value, and diagnostic accuracy of the H. pylori stool antigen test in patients with bleeding peptic ulcers were significantly lower than those in patients with nonbleeding peptic ulcers (p = .01, p = .02 and p = .003, respectively).Conclusion.  The H. pylori stool antigen test is not reliable for diagnosing H. pylori infection in patients with bleeding peptic ulcers.